BioNTech SE Total Liabilities

Latest as of March 2026: €2.38 Billion EUR ≈ $2.78 Billion USD

BioNTech SE total liabilities. Based on the latest financial reports, BioNTech SE (22UA) has total liabilities worth €2.38 Billion EUR (≈ $2.78 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of BioNTech SE to evaluate the company's liquid asset resilience ratio.

Total Liabilities of BioNTech SE (2016–2025)

Total liabilities of BioNTech SE from 2016 to 2025. This chart illustrates how BioNTech SE's total liabilities have evolved over time, based on quarterly financial data. Explore BioNTech SE (22UA) long-term investment share to see how much of total assets are deployed in long-term investments.

BioNTech SE Competitors by Total Liabilities

The table below lists competitors of BioNTech SE ranked by their total liabilities.

Company	Country	Total Liabilities
CHINA SHENHUA EN.A ADR/4 F:IKFC	Germany	€227.40 Billion
First Financial Holding Co Ltd TW:2892	Taiwan	NT$4.85 Trillion
Canon Inc F:CNNA	Germany	€2.69 Trillion
China United Network Communications Ltd SHG:600050	China	CN¥288.91 Billion
China Development Financial Holding Corp TW:2883	Taiwan	NT$3.65 Trillion
Fidelity National Information Services Inc NYSE:FIS	USA	$19.18 Billion
CLP HLDGS LTD ADR/1 HD 5 F:CLP1	Germany	€125.59 Billion
Yihai Kerry Arawana Holdings Co Ltd SHE:300999	China	CN¥131.25 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down BioNTech SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BioNTech SE total assets.

Liquidity & Leverage Metrics

BioNTech SE Total Liabilities Ratios Explained

BioNTech SE total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	8.80	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioNTech SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioNTech SE (2016–2025)

The table below shows the annual total liabilities of BioNTech SE from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€2.76 Billion ≈ $3.23 Billion	-11.36%
2024-12-31	€3.12 Billion ≈ $3.65 Billion	+12.98%
2023-12-31	€2.76 Billion ≈ $3.23 Billion	-14.37%
2022-12-31	€3.22 Billion ≈ $3.77 Billion	-18.13%
2021-12-31	€3.94 Billion ≈ $4.60 Billion	+315.84%
2020-12-31	€946.77 Million ≈ $1.11 Billion	+211.28%
2019-12-31	€304.15 Million ≈ $355.59 Million	-21.20%
2018-12-31	€385.99 Million ≈ $451.26 Million	-8.73%
2017-12-31	€422.92 Million ≈ $494.44 Million	+18.10%
2016-12-31	€358.10 Million ≈ $418.66 Million	--

About BioNTech SE

F:22UA Germany Biotechnology

Market Cap

$23.03 Billion

€19.70 Billion EUR

Market Cap Rank

#1251 Global

#287 in Germany

Share Price

€77.90

Change (1 day)

+0.58%

52-Week Range

€72.05 - €102.20

All Time High

€377.00